(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.80%) $79.62
(5.76%) $2.31
(1.23%) $2 350.90
(3.48%) $28.56
(1.02%) $994.60
(-0.29%) $0.927
(-0.37%) $10.85
(-0.21%) $0.798
(0.87%) $92.54
0.00% $ 0.000700
Live Chart Being Loaded With Signals
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis...
Stats | |
---|---|
Volumen de hoy | 274.00 |
Volumen promedio | 26 568.00 |
Capitalización de mercado | 49 991.00 |
EPS | $0 ( 2024-03-11 ) |
Próxima fecha de ganancias | ( $0 ) 2024-05-17 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-02-22 | Chandrasekhar Satishchandran | Buy | 0 | |
2021-09-09 | Saluck Randy S. | Buy | 60 000 | Common Stock, par value $0.005 per share |
2021-09-09 | Barbarick Steve K | Buy | 60 000 | Common Stock, par value $0.005 per share |
2021-09-09 | Verny Lea | Buy | 60 000 | Common Stock, par value $0.005 per share |
2021-09-28 | Markvicka Taunia | Buy | 100 000 | Common Stock, par value $0.005 per share |
INSIDER POWER |
---|
0.00 |
Last 70 transactions |
Buy: 2 421 695 | Sell: 3 004 967 |
Statera Biopharma, Inc. Correlación
10 Correlaciones Más Positivas | |
---|---|
NAKD | 0.946 |
BHTG | 0.935 |
TUEM | 0.935 |
LGMK | 0.932 |
MTEX | 0.93 |
GRIN | 0.923 |
AMGN | 0.918 |
PIII | 0.917 |
SMIT | 0.917 |
CREG | 0.916 |
10 Correlaciones Más Negativas | |
---|---|
ALGM | -0.974 |
ATRS | -0.966 |
QIPT | -0.965 |
FRSG | -0.965 |
XPDB | -0.963 |
ITAQ | -0.963 |
CRUS | -0.963 |
VPCB | -0.962 |
NPAB | -0.961 |
ACQR | -0.961 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Statera Biopharma, Inc. Finanzas
Annual | 2021 |
Ingresos: | $1.49M |
Beneficio Bruto: | $998 722 (67.16 %) |
EPS: | $-2.90 |
FY | 2021 |
Ingresos: | $1.49M |
Beneficio Bruto: | $998 722 (67.16 %) |
EPS: | $-2.90 |
FY | 2020 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.471 |
FY | 2019 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.126 |
Financial Reports:
No articles found.
Statera Biopharma, Inc.
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as expanding into fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. The company is based in Fort Collins, Colorado.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico